New cataract tool aims to save eye cells
NCT ID NCT07176416
First seen Sep 30, 2025 · Last updated Jun 21, 2026 · Updated 36 times
Summary
This study tests a new device called the Veritas Vision System for cataract surgery. The goal is to see if it uses less energy and causes less damage to the eye's inner lining compared to standard methods. Fifty adults having cataract surgery will be enrolled and followed for three months after their procedure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CATARACT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Aloha Vision Consultants
RECRUITING‘Aiea, Hawaii, 96701, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Veritas Vision System (a device for cataract surgery)
What this could lead to
If successful, this could lead to a safer, more efficient cataract surgery that causes less damage to the eye's inner lining.
What could go wrong
This is a small, early study with only 50 people. The new device may not show clear benefits over existing methods, and individual results may vary.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.